REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 185 filers reported holding REGENXBIO INC in Q2 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,415,560 | -12.0% | 86,000 | +6.8% | 0.00% | 0.0% |
| Q2 2023 | $1,609,195 | +7.2% | 80,500 | +1.4% | 0.00% | 0.0% |
| Q1 2023 | $1,501,454 | -25.4% | 79,400 | -10.5% | 0.00% | 0.0% |
| Q4 2022 | $2,011,716 | -12.4% | 88,700 | +2.1% | 0.00% | -50.0% |
| Q3 2022 | $2,297,000 | +8.7% | 86,900 | +1.5% | 0.00% | +100.0% |
| Q2 2022 | $2,114,000 | -16.1% | 85,600 | +12.8% | 0.00% | 0.0% |
| Q1 2022 | $2,519,000 | +9.3% | 75,900 | +7.7% | 0.00% | 0.0% |
| Q4 2021 | $2,305,000 | -22.0% | 70,500 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $2,955,000 | +8.8% | 70,500 | +0.9% | 0.00% | 0.0% |
| Q2 2021 | $2,716,000 | -7.1% | 69,900 | -18.4% | 0.00% | 0.0% |
| Q1 2021 | $2,923,000 | -10.1% | 85,700 | +19.5% | 0.00% | 0.0% |
| Q4 2020 | $3,252,000 | +64.8% | 71,700 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,973,000 | -24.0% | 71,700 | +1.7% | 0.00% | 0.0% |
| Q2 2020 | $2,597,000 | +24.6% | 70,500 | +9.5% | 0.00% | 0.0% |
| Q1 2020 | $2,085,000 | -19.7% | 64,400 | +1.6% | 0.00% | -33.3% |
| Q4 2019 | $2,597,000 | +18.0% | 63,400 | +2.6% | 0.00% | +50.0% |
| Q3 2019 | $2,200,000 | -29.7% | 61,800 | +1.5% | 0.00% | -33.3% |
| Q2 2019 | $3,128,000 | -7.2% | 60,900 | +3.6% | 0.00% | -25.0% |
| Q1 2019 | $3,370,000 | +44.2% | 58,800 | +5.6% | 0.00% | +33.3% |
| Q4 2018 | $2,337,000 | -38.2% | 55,700 | +11.2% | 0.00% | -25.0% |
| Q3 2018 | $3,783,000 | +8.1% | 50,100 | +2.7% | 0.00% | 0.0% |
| Q2 2018 | $3,501,000 | +155.5% | 48,800 | +6.3% | 0.00% | +100.0% |
| Q1 2018 | $1,370,000 | -3.2% | 45,900 | +7.7% | 0.00% | 0.0% |
| Q4 2017 | $1,416,000 | +0.9% | 42,600 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,404,000 | +66.9% | 42,600 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $841,000 | +2.3% | 42,600 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $822,000 | +35.9% | 42,600 | +30.7% | 0.00% | 0.0% |
| Q4 2016 | $605,000 | – | 32,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 831,014 | $15,714,475 | 6.51% |
| MPM BioImpact LLC | 617,671 | $11,680,159 | 3.03% |
| Sonic GP LLC | 193,079 | $3,651,124 | 2.79% |
| ArchPoint Investors | 224,278 | $4,241,097 | 1.84% |
| Redmile Group, LLC | 1,640,725 | $31,026,110 | 1.35% |
| MIRABELLA FINANCIAL SERVICES LLP | 25,983 | $5,461,344 | 0.83% |
| WS MANAGEMENT LLLP | 396,997 | $7,507,213 | 0.79% |
| Redwood Wealth Management Group, LLC | 15,190 | $287,243 | 0.33% |
| SummerHaven Investment Management, LLC | 27,503 | $520,082 | 0.30% |
| Lombard Odier Asset Management (Switzerland) SA | 130,369 | $2,465,278 | 0.22% |